Legend Biotech Corporation
LEGN
$19.67
-$0.25-1.23%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 126.48% | 46.24% | -217.12% | 68.33% | -589.16% |
| Total Depreciation and Amortization | 101.72% | 205.88% | 86.94% | 50.47% | 8.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -75.75% | -56.41% | 152.72% | -81.03% | 1,662.38% |
| Change in Net Operating Assets | -176.58% | -1.76% | 27.83% | 232.60% | -1,278.95% |
| Cash from Operations | -58.33% | 17.86% | 85.12% | 137.99% | -699.52% |
| Capital Expenditure | 18.48% | -275.00% | -421.24% | -142.37% | -169.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.02% | -162.06% | 861.01% | -104.53% | 77.42% |
| Cash from Investing | 27.49% | -165.47% | 826.39% | -106.08% | 76.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3,641.67% | -62.50% | -4.36% | 48.28% | -3.45% |
| Issuance of Common Stock | 70,766.67% | -92.86% | -47.02% | -76.48% | -85.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 18,733.33% | -300.00% | -95.47% | -84.22% | -194.24% |
| Foreign Exchange rate Adjustments | -106.82% | -185.71% | -12.58% | 441.41% | 48,788.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 115.13% | -264.84% | 461.06% | -95.23% | 74.84% |